Study to ONO-4538 in Patients With Rhabdoid Tumor
Recruiting
Phase 2
Interventional Study
Rhabdoid Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 1 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 23 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Gender: Not specified
2. Age (at the time of consent): 1 year or older
3. Patients who are refractory or intolerant to one or more regimens of chemotherapy for rhabdoid Tumors
4. Patients with advanced or recurrent rhabdoid Tumors not eligible for curative resection
Exclusio…
Contacts
North America Clinical Trial Support Desk
+18665877745(Toll-Free)
CONTACT
International Clinical Trial Support Desk
+17162141777(Standard)
CONTACT